// App-Quantinova.ai

: Time to event following bacillus Calmette-Guerin therapy initiation in Medicare beneficiaries with intermediate- to high-risk non-muscle invasive bladder cancer, 2010-2019.

Researchers

Presenter

  • Allison A. Petrilla

Principal Investigators

  • Alison R. Silverstein

  • Anthony Eccleston

  • Allison Thompson

  • Julia Brinkmann

  • Temitope Bello

  • Jane Chang

  • Joseph C Cappelleri

  • Sanjana Chandrasekar

  • Amy L Schroeder

Medical Centers

  • Pfizer Inc, New York, NY

  • Avalere Health LLC, Washington, DC

Locations

  • Germany

  • United Kingdom

  • United States

Companies

  • PharmAbcine Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Bladder Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved